Solutions
About Us
Insights
Careers
Contact us
Contact Us
Customer Support
Customer Support

Influence of Treatment Effect Modifiers in Fabry Disease: A Systematic Literature Review. Azimpour K, Tordoff-Gibson C, Dorling P, Koulinska I, Kunduri S, Laliman-Khara V, Forsythe A. Adv Ther. 2025

Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi Sarcoma. Lurain K, Ramaswami R, Ekwede I, Eulo V, Goyal G, Menon M, Odeny TA, Sharon E, Wagner MJ, Wang CJ, Bhardwaj N, Friedlander PA, Abdul-Hay M, Cornejo Castro EM, Labo N, Marshall VA, Miley W, Moore K, Roshan R, Whitby D, Kask AS, Kaiser J, Han E, Wright A, Yarchoan R, Fling SP, Uldrick TS. J Clin Oncol. 2025

Developing a prototype for federated analysis to enhance privacy and enable trustworthy access to COVID-19 research data. Eradat Oskoui S, Retford M, Forde E, Barnes R, J Hunter K, Wozencraft A, Thompson S, Orton C, Ford D, Heys S, Kennedy J, McNerney C, Peng J, Ghanbariadolat H, Rees S, H Mulholland R, Sheikh A, Burgner D, Brockway M, B Azad M, Rodriguez N, Zoega H, J Stock S, Calvert C, E Miller J, Fiorentino N, Racine A, Haggstrom J, Postlethwaite N. Int J Med Inform. 2025

Delayed Transition to 20-Valent Pneumococcal Conjugate Vaccine in Pediatric National Immunization Programs: Forgone Public Health and Economic Benefit. Perdrizet J, Ta A, Huang L, Wannaadisai W, Ilic A, Hayford K, Sabra A. Infect Dis Ther. 2025

Economic Evaluation of Transitioning to the 20-Valent Pneumococcal Conjugate Vaccine in the Dutch Paediatric National Immunisation Programme. Çakar E, Ta A, Peters M, Vinand E, Waterval-Overbeek A, Ilic A, Perdrizet J. Infect Dis Ther. 2025

Long-term risk of HCC in a DAA-treated national hepatitis C cohort, and a proposed risk score. Lybeck C, Bruce D, Szulkin R, Montgomery S, Aleman S, Duberg AS. Infect Dis (Lond). 2025

Conus medullaris termination: Assessing safety of spinal anesthesia in the L2-L3 interspace. Paul JE, Udovic LA, Oman K, Kim T, Bernstein L, Matteliano L, Singh N, Caldwell A, Vanniyasingam T, Thabane L. Acta Anaesthesiol Scand. 2025

Real-world therapy and persistence of patients with neovascular age-related macular degeneration and diabetic retinopathy or diabetic macular edema: a German claims data analysis. Krieger J, Cox O, Flacke JP, Beilschmidt L, Mueller S, Maywald U, Koss MJ. Graefes Arch Clin Exp Ophthalmol. 2025

Evaluating natalizumab first-line and later-line use in multiple sclerosis: a US claims database analysis. Avila RL, Croteau NS, Tang F, Simeone JC, Jomaa K, Bian B, Gianinazzi M. Ther Adv Neurol Disord. 2025

Health State Utility Values in Fabry Disease: Insights from the Pegunigalsidase Alfa Clinical Trials. Azimpour K, Dorling P, Koulinska I, Kunduri S, Lan Z, Poritz J, Tremblay G, Raad-Faherty A. Adv Ther. 2025